Publications by authors named "J Hoskins"

Proteostasis, the maintenance of cellular protein balance, is essential for cell viability and is highly conserved across all organisms. Newly synthesized proteins, or "clients," undergo sequential processing by Hsp40, Hsp70, and Hsp90 chaperones to achieve proper folding and functionality. Despite extensive characterization of post-translational modifications (PTMs) on Hsp70 and Hsp90, the modifications on Hsp40 remain less understood.

View Article and Find Full Text PDF
Article Synopsis
  • Identified noncoding driver mutations in pancreatic ductal adenocarcinoma (PDAC) by mapping accessible chromatin regions and histone modifications in pancreatic cell lines and tissues, integrating this data with whole-genome mutations from 506 PDAC cases.
  • *From 3,614 noncoding somatic mutations (NCSMs) found, 178 were shown to significantly affect gene activity, highlighting their potential role in cancer progression.
  • *Further experiments pinpointed specific genes impacted by these mutations, with a focus on one gene (KLF9) that showed reduced expression due to interference from NCSMs, establishing it as a possible PDAC driver gene.
View Article and Find Full Text PDF

Pancreatic Ductal Adenocarcinoma (PDAC) is the third leading cause of cancer-related deaths in the U.S. Both rare and common germline variants contribute to PDAC risk.

View Article and Find Full Text PDF

Genetic and epigenetic variations in regulatory enhancer elements increase susceptibility to a range of pathologies. Despite recent advances, linking enhancer elements to target genes and predicting transcriptional outcomes of enhancer dysfunction remain significant challenges. Using 3D chromatin conformation assays, we generated an extensive enhancer interaction dataset for the human pancreas, encompassing more than 20 donors and five major cell types, including both exocrine and endocrine compartments.

View Article and Find Full Text PDF

Objective: Genome wide association studies have identified an exon 6 deletion variant that associates with increased risk of pancreatic cancer. To acquire evidence on its causal role, we developed a new mouse strain carrying an equivalent variant in , the mouse orthologue of .

Design: We used CRISPR/Cas9 to introduce a 707bp deletion in encompassing exon 6 ( ).

View Article and Find Full Text PDF